Sumitomo Mitsui Trust Holdings, Inc. Crispr Therapeutics Ag Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $142 Billion
- Q3 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,968,034 shares of CRSP stock, worth $142 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,968,034
Previous 3,151,514
5.82%
Holding current value
$142 Million
Previous $170 Million
18.06%
% of portfolio
0.1%
Previous 0.13%
Shares
11 transactions
Others Institutions Holding CRSP
# of Institutions
491Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$380 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$359 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$143 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$142 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$133 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.74B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....